tag behavioural-science 
The Pharma Data
DECEMBER 21, 2020
The Behavioural Insights Unit of the WHO released a meeting report of the Technical Advisory Group (TAG) on the special session on acceptance and uptake of COVID-19 vaccines, held on 15 October 2020. The discussion was structured around three key questions. Click here to download image in full size. . Source link.
pharmaphorum
AUGUST 17, 2020
In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 29, 2021
1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries.
pharmaphorum
SEPTEMBER 29, 2021
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. As a general rule, avoid questionable behaviours and opinions especially when you’re representing your company or institution.
pharmaphorum
NOVEMBER 19, 2021
Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. The covid vaccine roll out is arguably the best example of why communications, and specifically behavioural science as part of that, plays such a pivotal role in healthcare.”. Pfizer is understood to have charged $19.50 per dose in the US and €19.50
Drug Discovery World
NOVEMBER 9, 2023
Peter O’Callaghan, PhD, Head of Expression System Sciences, Biologics and Licensing, Lonza, on: ‘Solve bispecific heavy-light chain mispairing with bYlok technology’. James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’.
Expert insights. Personalized for you.
52 
Let's personalize your content